Filing Details
- Accession Number:
- 0001493152-20-016100
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-17 16:30:32
- Reporting Period:
- 2020-08-13
- Accepted Time:
- 2020-08-17 16:30:32
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 868278 | Prophase Labs Inc. | PRPH | Pharmaceutical Preparations (2834) | 232577138 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1457896 | William Ted Karkus | 621 N. Shady Retreat Road Doylestown PA 18901 | Ceo & Chairman | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock, Par Value $0.005 | Disposition | 2020-08-13 | 50,000 | $2.75 | 2,419,528 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock, Par Value $0.005 | 40,000 | Indirect | By Son |
| Common Stock, Par Value $0.005 | 40,000 | Indirect | By Son |
Footnotes
- These shares were sold in a private transaction to Louis Gleckel, a director of the Issuer, pursuant to the terms of a Stock Purchase Agreement.
Billionaire Hedge Funds
